137 related articles for article (PubMed ID: 15108767)
1. Delayed occurrence of cardiac allograft vasculopathy in Chinese heart transplant recipients compared with their western counterparts.
Wang HJ; Ko WJ; Leea CM; Hsu RB; Chou NK; Wang SS; Liau CS; Chu SH; Lee YT
Clin Transplant; 2004 Feb; 18(1):21-7. PubMed ID: 15108767
[TBL] [Abstract][Full Text] [Related]
2. Low incidence of transplant coronary artery disease in Chinese heart recipients.
Hsu RB; Chu SH; Wang SS; Ko WJ; Chou NK; Lee CM; Chen MF; Lee YT
J Am Coll Cardiol; 1999 May; 33(6):1573-7. PubMed ID: 10334426
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients.
Johansson I; Andersson R; Friman V; Selimovic N; Hanzen L; Nasic S; Nyström U; Sigurdardottir V
BMC Infect Dis; 2015 Dec; 15():582. PubMed ID: 26703239
[TBL] [Abstract][Full Text] [Related]
4. Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation.
Delgado JF; Reyne AG; de Dios S; López-Medrano F; Jurado A; Juan RS; Ruiz-Cano MJ; Dolores Folgueira M; Gómez-Sánchez MÁ; Aguado JM; Lumbreras C
J Heart Lung Transplant; 2015 Aug; 34(8):1112-9. PubMed ID: 25940077
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of cardiac allograft vasculopathy: Importance of the International Society for Heart and Lung Transplantation angiographic grading scale.
Van Keer JM; Van Aelst LNL; Rega F; Droogne W; Voros G; Meyns B; Vanhaecke J; Emonds MP; Janssens S; Naesens M; Van Cleemput J
J Heart Lung Transplant; 2019 Nov; 38(11):1189-1196. PubMed ID: 31543298
[TBL] [Abstract][Full Text] [Related]
6. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
[TBL] [Abstract][Full Text] [Related]
7. Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study.
Mehra MR; Stapleton DD; Ventura HO; Escobar A; Cassidy CA; Smart FW; Collins TJ; Ramee SR; White CJ
Circulation; 1994 Nov; 90(5 Pt 2):II78-82. PubMed ID: 7955289
[TBL] [Abstract][Full Text] [Related]
8. The Association Between Cytomegalovirus Infection and Cardiac Allograft Vasculopathy in the Era of Antiviral Valganciclovir Prophylaxis.
Klimczak-Tomaniak D; Roest S; Brugts JJ; Caliskan K; Kardys I; Zijlstra F; Constantinescu AA; Voermans JJC; van Kampen JJA; Manintveld OC
Transplantation; 2020 Jul; 104(7):1508-1518. PubMed ID: 31644496
[TBL] [Abstract][Full Text] [Related]
9. Diminished impact of cytomegalovirus infection on graft vasculopathy development in the antiviral prophylaxis era - a retrospective study.
Goekler J; Zuckermann A; Kaider A; Angleitner P; Osorio-Jaramillo E; Moayedifar R; Uyanik-Uenal K; Kainz FM; Masetti M; Laufer G; Aliabadi-Zuckermann AZ
Transpl Int; 2018 Aug; 31(8):909-916. PubMed ID: 29577455
[TBL] [Abstract][Full Text] [Related]
10. Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients.
Asimacopoulos EP; Garbern JC; Gauvreau K; Blume ED; Daly KP; Singh TP
Transplantation; 2020 Jan; 104(1):e31-e37. PubMed ID: 31568274
[TBL] [Abstract][Full Text] [Related]
11. The policy of placing older donors into older recipients: is it worth the risk?
Tehrani YS; Yu Z; Luu M; Liou F; Rafiei M; Hamilton M; Kobashigawa JA
Clin Transplant; 2014 Jul; 28(7):802-7. PubMed ID: 24801014
[TBL] [Abstract][Full Text] [Related]
12. Identification and Characterization of Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation: A Population-Based Study.
Loupy A; Coutance G; Bonnet G; Van Keer J; Raynaud M; Aubert O; Bories MC; Racapé M; Yoo D; Duong Van Huyen JP; Bruneval P; Taupin JL; Lefaucheur C; Varnous S; Leprince P; Guillemain R; Empana JP; Levine R; Naesens M; Patel JK; Jouven X; Kobashigawa J
Circulation; 2020 Jun; 141(24):1954-1967. PubMed ID: 32363949
[TBL] [Abstract][Full Text] [Related]
13. Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients.
Kobayashi D; Du W; L'ecuyer TJ
Pediatr Transplant; 2013 Aug; 17(5):436-40. PubMed ID: 23714284
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients.
Daly KP; Stack M; Eisenga MF; Keane JF; Zurakowski D; Blume ED; Briscoe DM
J Heart Lung Transplant; 2017 Apr; 36(4):434-442. PubMed ID: 27865734
[TBL] [Abstract][Full Text] [Related]
15. Uncertain benefit of statins in pediatric heart transplant recipients: A PHTS analysis.
Townsend M; Khoury M; Koehl D; Kirklin JK; Cantor R; Beasley G; Chen CY; Boyle G; Parent JJ; Baez Hernandez N; Halnon N
J Heart Lung Transplant; 2024 May; 43(5):703-713. PubMed ID: 38065240
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy.
Sharples LD; Jackson CH; Parameshwar J; Wallwork J; Large SR
Transplantation; 2003 Aug; 76(4):679-82. PubMed ID: 12973108
[TBL] [Abstract][Full Text] [Related]
17. Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation.
Raichlin E; Edwards BS; Kremers WK; Clavell AL; Rodeheffer RJ; Frantz RP; Pereira NL; Daly RC; McGregor CG; Lerman A; Kushwaha SS
J Heart Lung Transplant; 2009 Apr; 28(4):320-7. PubMed ID: 19332257
[TBL] [Abstract][Full Text] [Related]
18. Pravastatin therapy is associated with reduction in coronary allograft vasculopathy in pediatric heart transplantation.
Mahle WT; Vincent RN; Berg AM; Kanter KR
J Heart Lung Transplant; 2005 Jan; 24(1):63-6. PubMed ID: 15653381
[TBL] [Abstract][Full Text] [Related]
19. Cardiac allograft rejection late after transplantation is a risk factor for graft coronary artery disease.
Brunner-La Rocca HP; Schneider J; Künzli A; Turina M; Kiowski W
Transplantation; 1998 Feb; 65(4):538-43. PubMed ID: 9500630
[TBL] [Abstract][Full Text] [Related]
20. Risk Stratification for Cardiac Allograft Vasculopathy in Heart Transplant Recipients - Annual Intravascular Ultrasound Evaluation.
Sato T; Seguchi O; Ishibashi-Ueda H; Yanase M; Okada N; Kuroda K; Hisamatsu E; Sunami H; Watanabe T; Nakajima S; Wada K; Hata H; Fujita T; Fukushima N; Kobayashi J; Nakatani T
Circ J; 2016; 80(2):395-403. PubMed ID: 26701183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
